IL13 and breast carcinoma: In another study, “protumor” M2-polarized macrophages in the microenvironment of breast cancer were augmented after IL-13 administration, which further mediated tumor radioresistance; however, inhibition of IL-13-mediated M2 polarization of macrophages by PM37 could prevent radioresistance (139).